ABsTRAcr Infection has been the major cause of death and morbidity in patients undergoing cardiac transplantation at Groote Schuur Hospital. Twenty-two (55%) patients suffered at least one major episode of infection, which accounted for 10 (59%) of the deaths in the first year. The major site of origin of infection was the lung, though dissemination was not infrequent. Bacteria accounted for 22 (59%) infections; but viral, fungal and protozoal infections were not uncommon and in fact accounted for seven (64%) of the fatal infections. Several unusual causative microorganisms have been isolated in this group of immunocompromised subjects. There is a higher incidence of infection in patients over the age of 35 years and in patients who did not comply with instructions and advice.
Infection is the major cause of death in patients undergoing cardiac transplantation, especially in the first few months when immunosuppression is heaviest. ' 2 Patients are susceptible to infection by a wide range of pathogens, bacterial infection being by far the most common; other organisms primarily responsible include viruses, fungi, and protozoa.3 We report our experience with such infections in recipients of heterotopic heart transplants over the past seven years.
The patients From 25 November 1974 to 29 October 1981 44 heterotopic heart transplants were performed in 40 patients, four patients undergoing retransplantation after irreversible rejection; all have been followed up for at least five months. Details of the selection and management of patients have been described previously.2
The basic immunosuppressive treatment throughout this period has consisted of: (1) azathioprine at the highest tolerated level as judged by the absence of bone marrow and hepatic toxicity, the maintenance dose for adults being 1-5-4-0 mg/kg/day; (2) methylprednisolone 600 mg given intravenously on the day of operation and reduced by daily increments of 100 mg until discontinued on the sixth postoperative day, after which time oral doses of 64 mg/day have been administered, reducing to about 32 mg/day at three months if the progress of the patient permits; (3) from 1970 to 1979 equine antilymphocyte globulin was given intravenously during the first month, in doses related to its effect on T cell rosetting; rabbit antithymocyte globulin has been used since mid-1979 . Acute rejection episodes have been treated with three to five daily intravenous pulses of methylprednisolone and short courses of RATG and/or actinomycin D (200 ,g/day for 3 to 4 days).
Attention was paid to the location and elimination of all sources of infection before transplantation. Patients with active infection or conditions which might predispose to infection, such as diabetes mellitus requiring insulin, were not selected for transplantation. Perioperative antibiotic prophylaxis at the time of transplantation consisted of cephamandole nafate 1 g intravenously on induction of anaesthesia, followed by 1 g intravenously six hourly for four days. After transplantation observation for clinical symptoms and signs of infection was continuous, laboratory investigation urgent and intense, and treatment aggressive. Specific treatment was withheld until the infecting organism had been positively identified, unless identification proved impossible in life threatening conditions. 822 Though bacteria accounted for 59% of all fatal and non-fatal infections, fungi and viruses accounted for 64% of all fatal infections (seven of 11). Indeed, three of four fungal infections were fatal, reflecting the great difficulty experienced in eradicating these organisms in immunosuppressed patients.
Gas gangrene of the leg occurred in one patient, amputation being unsuccessful in delaying death. The source of the Clostridium perfringens was uncertain, but possibly followed an endomyocardial biopsy performed through the femoral vein a few days previously. At necropsy the organism was also grown from the lungs. Fungal pneumonia has been a considerable problem, particularly with Aspergillus sp. Petriellidium boydii was found at necropsy in one patient, the findings suggesting primary infection of the lungs with haematogenous dissemination to the brain (fig  1) , kidneys, and skin. 4 Fatal viral infections were thought to have occurred in three patients, though the evidence was inconclusive in two. In one there were pathognomonic inclusion bodies of cytomegalovirus in many organs at necropsy. In a second patient inclusion bodies of a herpetic type were seen in several organs, but although the patient died with clinical and histological encephalitis no virus was isolated from the cerebrospinal fluid or from the brain. The third patient developed a severe pneumonia, though no micro-organisms could be cultured; at necropsy there were histological features which supported a diagnosis of viral pneumonia. Evidence of herpesvirus infection and of cytomegalovirus infection were present in about 40% of patients dying of other causes.4
NON-FATAL INFECTIONS
Non-fatal infections are listed in table 3. Again, the lung was the most common site of infection, being affected in a quarter of the cases. Certain cases are worthy of comment.
Eighteen months after heterotopic heart transplantation endocarditis caused by Staphylococcus aureus developed on an aortic valve prosthesis in the patient's own heart; antibiotic treatment was unsuccessful. The prosthesis was removed, the recipient's left ventricle being partially resected and excluded from the circulation. The patient made an excellent recovery, since when he has been symptom free; over seven years later he is our longest survivor.5
Two patients developed severe postoperative sternal wound infections, both of which were extremely difficult to eradicate. In one the original infecting organism was Staphylococcus aureus, but subsequently seven further organisms were grown from discharging sinuses in this tegion. During the course of two years the patient underwent nine operative procedures in an attempt to eradicate this infection. Chronic discharging sinuses remained for some 36 months but then spontaneously healed, the patient dying of chronic rejection in his fifth postoperative year. In the second patient the original infecting organism remains uncertain, though Enterobacter sp and Staphylococcus epidermidis were the first organisms cultured from the pus exuding from the wound. Eight further organisms, including Aspergillus sp and Clostridium perfringens, were cultured subsequently. The patient underwent three surgical drainage procedures before the infection Minor herpes simplex infections are very common in immunosuppressed patients, but herpes zoster has also occurred on three occasions, though it has not become disseminated.
Toxoplasmosis was found on endomyocardial biopsy of both donor and recipient hearts in one patient (fig 2) , though at no time did the patient develop clinical signs of disseminated infection.6 While the infection could have been opportunistic, two other possibilities must be considered. Firstly, the patient's idiopathic cardiomyopathy may have been due to toxoplasmosis; an absence of toxoplasma antibodies before transplantation and a raised titre after transplantation (1/1024), however, argue against prior infection in the recipient. Secondly, the donor could have had toxoplasmosis, the organism being transferred with the donor heart. The donor did have a mildly raised antibody titre (1I256)7 to toxoplasma so the recipient could have been infected from the donor, although the organism was not seen in endomyocardial biopsy specimens taken in the first month. After treatment, the organism was not seen again on biopsy and the recipient's antibody titres fell to lower levels.
That immunosuppressed patients remain at risk from serious infection even when receiving low doses of drugs is illustrated by one of our patients, who during the fifth year after transplantation developed Pneumocystis carinii pneumonia followed shortly by cryptococcal meningitis; his local physicians successfully treated both episodes.
Discussion
In patients undergoing heterotopic heart transplantation at Groote Schuur Hospital infection is the major cause of death during the first year after transplantation. The Stanford group has reported an even higher proportion of deaths from infection (58%). Whether the greater incidence of fatal infection at Stanford is related to differences in the immunosuppressive regimen used at the two centres is uncertain, though possibly a rather greater emphasis has been placed on rabbit antithymocyte globulin at Stanford than in Cape Town.' 2 Our impression has been that during the first three months after transplantation infection not infrequently follows increased immunosuppressive treatment in patients undergoing acute rejection episodes, particularly if such episodes are repeated or prolonged. After three months infectious episodes would appear to be less clearly related to the level of immunosuppressive treatment.
The lung was clearly the most common site for infection in our series, though not infrequently dissemination took place (tables 2 and 4). A higher incidence of purely pulmonary infections has been reported from Stanford with a lower incidence of disseininated infection (table 5) .3 Minor differences between the two series include a greater number of urinary tract infections at Stanford and of bone infections at Groote Schuur. None of these differences would appear to be related to the different type of operation performed at Stanford (orthotopic as opposed to heterotopic transplantation).
The causal organisms responsible for infectious episodes at the two centres are very similar, bacterial infection accounting for about 60% in both series.3 were in patients with ischaemic heart disease. The higher incidence of infection in ischaemic heart disease patients may well be related to their greater mean age (41 years compared with 30 years for those with cardiomyopathy).
We found a high incidence of infectious complications in patients who for one reason or another did not comply with medical advice and instructions. On occasion this was due to a mild depressive disorder, but more frequently it was due to a casual approach or even irresponsibility on the part of the patient. The possible reasons for non-compliance will be discussed elsewhere. '5 The operation of heterotopic heart transplantation requires insertion of a graft of prosthetic material, such as Dacron, between donor and recipient pulmonary arteries. The presence of prosthetic material in an immunosuppressed patient might be associated with a risk of infection but so far no such complication has occurred. Infection remains the major cause of death and a major cause of morbidity during the first year after transplantation. If the patient is to be given the best chance of long term survival, the clinician must be observant for symptoms and signs of infection, clinical investigation in suspicious cases must be urgent and thorough, laboratory investigation must include a search for unusual micro-organisms not frequently met in non-immunocompromised patients, and treatment must be early and aggressive.
